Elite Pharmaceuticals Inc (ELTP)

[lasers]

Yes that is correct and we all await to learn of the ELI-200 agreement with EPIC for the $15 mil up front in milestones and the cost of marketing. It is a five year agreement. More realistically a 40 PE and perhaps a 50% split with EPIC would still be $ELTP $38 PPS.

Immediately following and/or coincidentally, with the ELI-200 approval/launch, $ELTP will be submitting several other agonists opioids for approval. All of these other ELIs (201, 202, 216 etc.)have the same Naltrexone delivery sequestering polymer and should be a mere formality for the FDA approval. Launching other ELIs agonists on a 100% ownership $ELTP basis and $ELTP agressively competes for the remaining 80% of the $12 Bil Opioid Mkt.